Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Financing gene therapy beyond phase II

A Michael

    Gene Therapy
    |December 1, 1996
    PubMed
    Summary
    This summary is machine-generated.

    Developing gene therapies is a monumental task, with approximately 250 protocols costing billions. Current funding levels are insufficient to bring even a few of these groundbreaking treatments to market.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Challenging Spontaneous Quantum Collapse with the XENONnT Dark Matter Detector.

    Physical review letters·2026
    Same author

    WIMP Dark Matter Search Using a 3.1 Tonne-Year Exposure of the XENONnT Experiment.

    Physical review letters·2025
    Same author

    Search for Light Dark Matter in Low-Energy Ionization Signals from XENONnT.

    Physical review letters·2025
    Same author

    First Search for Light Dark Matter in the Neutrino Fog with XENONnT.

    Physical review letters·2025
    Same author

    First Indication of Solar ^{8}B Neutrinos via Coherent Elastic Neutrino-Nucleus Scattering with XENONnT.

    Physical review letters·2024
    Same author

    Malaria Diagnosis at the Pediatric Emergency Unit of a Teaching Hospital in Makurdi, North Central Nigeria.

    Ethiopian journal of health sciences·2024
    Same journal

    Improving the precision of AAV lung gene therapy for SP-B deficiency using computationally derived lung-specific promoters.

    Gene therapy·2026
    Same journal

    Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

    Gene therapy·2026
    Same journal

    Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

    Gene therapy·2026
    Same journal

    Applications of genome editing technologies in the treatment of human diseases.

    Gene therapy·2026
    Same journal

    High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation.

    Gene therapy·2026
    Same journal

    AAV8-mediated mouse/human PROC expression rescues thrombophilia in hereditary protein C-deficient mice.

    Gene therapy·2026
    See all related articles

    Area of Science:

    • Biotechnology
    • Medical Economics
    • Genetics

    Background:

    • Gene therapy development involves numerous protocols, with most in early stages.
    • The projected market entry cost for each gene therapy protocol is substantial, ranging from $100 million to $200 million.
    • The total estimated cost to bring all current gene therapy protocols to market is $37.5 billion.